Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Feldheim

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Neurological Research and Practice|May 25, 2021
Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodiesJonas Feldheim, Cornelius Deuschl, Martin Glas, et al.
Cancers|November 27, 2019
Changes of O<sup>6</sup>-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse-A Meta-Analysis Type Literature ReviewJonas Feldheim, Almuth F Kessler, Camelia M Monoranu, et al.
Biomedicines|July 9, 2020
Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma PatientsAlmuth F Kessler, Jonas Feldheim, Dominik Schmitt, et al.
Cancers|August 26, 2023
Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to DeafnessMaria Breun, Katharina Flock, Jonas Feldheim, et al.
Cancers|May 1, 2020
Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma-A New Disease Biomarker?Jonas Feldheim, Almuth F Kessler, Dominik Schmitt, et al.
Oncotargets and Therapy|December 26, 2018
Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patientsJonas Feldheim, Almuth F Kessler, Dominik Schmitt, et al.
Fluids and Barriers of the CNS|April 24, 2020
Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier modelCarolin J Curtaz, Constanze Schmitt, Saskia-Laureen Herbert, et al.
Cancers|January 25, 2025
Prognostic Factors in Therapy Regimes of Breast Cancer Patients with Brain Metastases: A Retrospective Monocentric AnalysisCarolin Julia Curtaz, Judith Harms, Constanze Schmitt, et al.
International Journal of Molecular Sciences|April 12, 2022
Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain MetastasesCarolin J Curtaz, Leonie Reifschläger, Linus Strähle, et al.
Cancers|June 10, 2023
BRMS1 in Gliomas-An Expression AnalysisJonas Feldheim, Almuth F Kessler, Julia J Feldheim, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Neurological Research and Practice|May 25, 2021
Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodiesJonas Feldheim, Cornelius Deuschl, Martin Glas, et al.
Cancers|November 27, 2019
Changes of O<sup>6</sup>-Methylguanine DNA Methyltransferase (MGMT) Promoter Methylation in Glioblastoma Relapse-A Meta-Analysis Type Literature ReviewJonas Feldheim, Almuth F Kessler, Camelia M Monoranu, et al.
Biomedicines|July 9, 2020
Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma PatientsAlmuth F Kessler, Jonas Feldheim, Dominik Schmitt, et al.
Cancers|August 26, 2023
Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to DeafnessMaria Breun, Katharina Flock, Jonas Feldheim, et al.
Cancers|May 1, 2020
Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma-A New Disease Biomarker?Jonas Feldheim, Almuth F Kessler, Dominik Schmitt, et al.
Oncotargets and Therapy|December 26, 2018
Expression of activating transcription factor 5 (ATF5) is increased in astrocytomas of different WHO grades and correlates with survival of glioblastoma patientsJonas Feldheim, Almuth F Kessler, Dominik Schmitt, et al.
Fluids and Barriers of the CNS|April 24, 2020
Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier modelCarolin J Curtaz, Constanze Schmitt, Saskia-Laureen Herbert, et al.
Cancers|January 25, 2025
Prognostic Factors in Therapy Regimes of Breast Cancer Patients with Brain Metastases: A Retrospective Monocentric AnalysisCarolin Julia Curtaz, Judith Harms, Constanze Schmitt, et al.
International Journal of Molecular Sciences|April 12, 2022
Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain MetastasesCarolin J Curtaz, Leonie Reifschläger, Linus Strähle, et al.
Cancers|June 10, 2023
BRMS1 in Gliomas-An Expression AnalysisJonas Feldheim, Almuth F Kessler, Julia J Feldheim, et al.
Pageof 2